Literature DB >> 19632603

Surgical pathology to describe the clinical margin of debridement of chronic wounds using a wound electronic medical record.

Michael S Golinko1, Renata Joffe, David de Vinck, Eashwar Chandrasekaran, Olivera Stojadinovic, Stephan Barrientos, Sasa Vukelic, Marjana Tomic-Canic, Harold Brem.   

Abstract

BACKGROUND: Chronic wounds, including diabetic foot ulcers (DFU), pressure ulcers (PU), and venous ulcers (VU) result from multiple physiologic impairments. Operative debridement is a mainstay of treatment to remove nonviable tissue and to stimulate wound healing. Unlike tumor resection, however, operative wound specimens are not routinely sent for pathology. The objective of this study was to describe the pathology present in chronic wounds. STUDY
DESIGN: Pathology reports of the skin edge and wound base from 397 initial debridements in 336 consecutive patients with chronic wounds were retrospectively reviewed. All data were entered and stored in a Wound Electronic Medical Record. Pathology data were extracted from the Wound Electronic Medical Record, coded, and quantified.
RESULTS: Up to 15 distinct histopathologic findings across 7 tissue types were observed after review of pathology reports from chronic wounds. Specifically, the pathology of epidermis revealed hyperkeratosis: 66% in DFUs, 31% in PUs, and 29% in VUs. Dermal pathology revealed fibrosis in 49% of DFUs, 30% of PUs, and 15% of VUs. Wound bed pathology revealed necrosis in the subcutaneous tissue in 67% of DFUs, 55% of PUs, and 19% of VUs. Fibrosis was reported in between 19% and 52% of all wound types. Acute osteomyelitis was present in 39% of DFUs, 33% of PUs, and 29% of VUs.
CONCLUSIONS: This observational study of the histopathology of initial surgical debridement of chronic wounds revealed a wide range of findings across multiple tissue levels. Although certain findings such as osteomyelitis and gangrene have been shown to directly relate to impaired wound healing and amputation, other findings require additional investigation. To rigorously define a margin of debridement, a prospective study relating histopathology and clinical outcomes such as healing rates and amputation is needed.

Entities:  

Mesh:

Year:  2009        PMID: 19632603     DOI: 10.1016/j.jamcollsurg.2009.04.012

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  10 in total

1.  Effects of external application of Chinese medicine on diabetic ulcers and the expressions of β-catenin, c-myc and K6.

Authors:  Fu-Lun Li; Hui Deng; Hong-Wei Wang; Rong Xu; Jie Chen; Yi-Fei Wang; Xin Li; Bin Fan; Bin Li
Journal:  Chin J Integr Med       Date:  2011-04-21       Impact factor: 1.978

2.  Chronic wound repair and healing in older adults: current status and future research.

Authors:  Lisa Gould; Peter Abadir; Harold Brem; Marissa Carter; Teresa Conner-Kerr; Jeff Davidson; Luisa DiPietro; Vincent Falanga; Caroline Fife; Sue Gardner; Elizabeth Grice; John Harmon; William R Hazzard; Kevin P High; Pamela Houghton; Nasreen Jacobson; Robert S Kirsner; Elizabeth J Kovacs; David Margolis; Frances McFarland Horne; May J Reed; Dennis H Sullivan; Stephen Thom; Marjana Tomic-Canic; Jeremy Walston; Jo Anne Whitney; John Williams; Susan Zieman; Kenneth Schmader
Journal:  J Am Geriatr Soc       Date:  2015-03-06       Impact factor: 5.562

3.  A Perioperative Approach to Increase Limb Salvage When Treating Foot Ulcers in Patients With Diabetes.

Authors:  Raelina S Howell; Theresa Criscitelli; Jon S Woods; Brian M Gillette; Harold Brem; Scott Gorenstein
Journal:  AORN J       Date:  2018-04       Impact factor: 0.676

4.  Histopathological comparisons of Staphylococcus aureus and Pseudomonas aeruginosa experimental infected porcine burn wounds.

Authors:  Sarah B Chaney; Kasturi Ganesh; Shomita Mathew-Steiner; Paul Stromberg; Sashwati Roy; Chandan K Sen; Daniel J Wozniak
Journal:  Wound Repair Regen       Date:  2017-05-18       Impact factor: 3.617

5.  Chronic wound repair and healing in older adults: current status and future research.

Authors:  Lisa Gould; Peter Abadir; Harold Brem; Marissa Carter; Teresa Conner-Kerr; Jeff Davidson; Luisa DiPietro; Vincent Falanga; Caroline Fife; Sue Gardner; Elizabeth Grice; John Harmon; William R Hazzard; Kevin P High; Pamela Houghton; Nasreen Jacobson; Robert S Kirsner; Elizabeth J Kovacs; David Margolis; Frances McFarland Horne; May J Reed; Dennis H Sullivan; Stephen Thom; Marjana Tomic-Canic; Jeremy Walston; JoAnne Whitney; John Williams; Susan Zieman; Kenneth Schmader
Journal:  Wound Repair Regen       Date:  2015-02-13       Impact factor: 3.617

6.  Quality assessment of tissue specimens for studies of diabetic foot ulcers.

Authors:  Olivera Stojadinovic; Jennifer N Landon; Katherine A Gordon; Irena Pastar; Julia Escandon; Alejandra Vivas; Andrea D Maderal; David J Margolis; Robert S Kirsner; Marjana Tomic-Canic
Journal:  Exp Dermatol       Date:  2013-03       Impact factor: 3.960

Review 7.  Epithelial-mesenchymal transition in tissue repair and fibrosis.

Authors:  Rivka C Stone; Irena Pastar; Nkemcho Ojeh; Vivien Chen; Sophia Liu; Karen I Garzon; Marjana Tomic-Canic
Journal:  Cell Tissue Res       Date:  2016-07-27       Impact factor: 5.249

8.  A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers.

Authors:  Rivka C Stone; Olivera Stojadinovic; Andrew P Sawaya; George D Glinos; Linsey E Lindley; Irena Pastar; Evangelos Badiavas; Marjana Tomic-Canic
Journal:  Wound Repair Regen       Date:  2019-12-04       Impact factor: 3.617

9.  Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months' duration.

Authors:  Hassan Gubara Musa; Mohamed Elmakki Ahmed
Journal:  Diabet Foot Ankle       Date:  2012-10-30

Review 10.  Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response.

Authors:  Rivka C Stone; Vivien Chen; Jamie Burgess; Sukhmani Pannu; Marjana Tomic-Canic
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.